COHANCE
Cohance Lifesciences Limited
Pharmaceuticals
Share price
₹462
Market cap
₹17,676 Cr
1Y return
▼ 21%
A Hyderabad-based contract development and manufacturing organization serving leading global pharmaceutical and fine chemical companies. Cohance Life provides integrated services spanning process research and development through late-stage clinical and commercial manufacturing for new chemical entities. The company distinguishes itself through its commitment to delivering customized solutions that fulfill specific customer needs and expectations across the entire drug development lifecycle.
Investors holding Cohance Lifesciences Limited
3.73%
2.90%
2.18%
2.16%
1.75%
1.61%
Recent moves 12
Moves12
Invesco Mutual FundDecreased
Invesco Mutual Fund sold 3,07,571 shares of Cohance Lifesciences Limited, reducing its stake from 1.69% to 1.61%.
Read more
Amansa HoldingsNew position
Amansa Holdings added over 1.18% of Cohance Lifesciences Limited and now holds 2.18%, or 83,35,592 shares.
Read more
DSP Mutual FundDecreased
DSP Mutual Fund reduced its stake in Cohance Lifesciences from 4.28% to 2.90%, selling 52,97,234 shares.
Read more
SBI Mutual FundIncreased
SBI Mutual Fund increased its stake in Cohance Lifesciences from 3.33% to 3.73%. The fund house acquired 15,46,283 shares during the period, raising its total holding to 1,42,81,118 shares.
Read more
ICICI Prudential Mutual FundDecreased
ICICI Prudential Mutual Fund cut its stake in Cohance Lifesciences from 4.19% to 3.68%, selling 19,37,750 shares.
Read more
DSP Mutual FundDecreased
DSP Mutual Fund reduced its stake in Cohance Lifesciences from 4.29% to 3.53% by selling 28,99,996 shares in an open market transaction on August 7, 2026.
Read more
ICICI Prudential Mutual FundDecreased
ICICI Prudential Mutual Fund decreased its stake in Cohance Lifesciences from 4.49% to 4.19%, selling 11,44,549 shares.
Read more
HDFC Mutual FundDecreased
HDFC Mutual Fund trimmed its stake in Cohance Lifesciences from 3.14% to 2.16%, selling 37,44,543 shares.
Read more
SBI Life InsuranceDecreased
SBI Life Insurance reduced its stake in Cohance Lifesciences from 2.02% to 1.75% by selling 10,25,469 shares.
Read more
SBI Mutual FundNew position
SBI Mutual Fund took a new position in Cohance Lifesciences, acquiring 1,27,34,835 shares for a 3.33% stake.
Read more
Track the whales in Cohance Lifesciences Limited
Get alerted the moment a top investor buys or sells.
Start 7 days for ₹1